ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CARYTRE who wrote (1206)	1/18/1998 8:52:00 PM
From: Frank Buck	Read Replies (1) of 1894

Cary, I think the last PR firm told the Company that silence was the best policy. How much did that cost us? We paid for that in two ways! The product development bill just got cut in half! There should be enough funds for a conservative buyback. Stimulating the share price to a level that makes warrant holders exercise and institutions interested in buying at this point is a good thing. Otherwise AccuMed might get stuck in a low "trading range" when the old 52 week high time period is expired. Then the 52 week high becomes progressively lower. Yes it is a race to raise the share price. Also at this price level and market capitalization, AccuMed can be bought out by another company. Good many might say...but an acquiror might use stock in lieu of cash. Not always that good for the acquired shareholders. The gamble might be: Can AccuMed raise the current stock price with a buyback and simultaneously recoup the cash from the the warrant holder purchases. It doesn't become a moot point because: The stock price would be raised, the event will be market-positive, the buyback affects all future quarters, and the impact will be "timely" to minimize any gamble risks. The biggest benefactors will be the shareholders. The three dollar price range may be an obstacle, just like $2.25 is currently. The stock-price has to be sustained above $3.125 to make the warrant holders exercise. How else is AccuMed going to blow past that range? A Wall Street PP firm would take $100K as an expense-retainer to boost the share price. Please rethink this one. It is going to take something more than strong sounding press releases and words right now to raise the share price. We already have strong-buy analyst ratings, the news is out about the venture, the 10th day of January is past for insider reportings being filed and January is half over. Something immediate and permanent are needed. Volume needs to be stirred up. A buyback will grab attention. It will tell existing shareholders who are already planning on selling at their original buy-in range that the Company is serious. The past two blown quarters need to be atoned for. A stock-buyback will signal that atonement. Shareholders have been told a lot of things in the past nine months. The recent fall to a 52 week low shows that many shareholders and market-makers were not sticking around to see when numbers were going to meet the stated expectations. An announcement of a share buy back will make everyone who has ever had anything to do with AccuMed take notice. Actions speak louder than words. Frank

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next